Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

Eye burning

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Eye lacrimation

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Foreign body sensation

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Rhinorrhea

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Nasal congestion

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Nasal pruritus

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Eyelid swelling

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Visual Acuity

Improve from baseline.

Time frame: Baseline and Day 60

Meniscus height

Differences between treatments.

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Conjunctival hyperemia

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Chemosis

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Eye discharge

Differences between treatments. Scale 0-3 (none, mild, moderate, severe)

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60

Conjuctival impression cytology

Differences between treatments. Nelson classification.

Time frame: Baseline, Day 30, Day 60

Adverse reactions

Time frame: Baseline, Day 15, Day 30, Day 45, Day 60.